Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  258 results for ""Angiotensin II Type 1 Receptor Blockers""

Your Filters

Subject : stroke
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Comparison of the Effect of Fimasartan versus Valsartan on Blood Pressure Variability in Acute Ischemic Stroke: A Double-Blind Randomized Trial.

  • Authors : Shin DH; Department of Neurology, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.; Song S

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Biphenyl Compounds/Biphenyl Compounds/Biphenyl Compounds/*therapeutic use ; Blood Pressure/Blood Pressure/Blood Pressure/*drug effects

  • Source: Cardiovascular therapeutics [Cardiovasc Ther] 2019 Jun 02; Vol. 2019, pp. 7836527. Date of Electronic Publication: 2019 Jun 02 (Print Publication: 2019).Publisher: Hindawi Country of Publication: England NLM ID: 101319630 Publication Model: eCollection Cited Medium: Internet ISSN: 1755-5922

Record details

Read More Add to Saved list
×
Academic Journal

Hemilingual Angioedema after Thrombolysis in a Patient on an Angiotensin II Receptor Blocker.

  • Authors : Diestro JDB; Department of Neurosciences, College of Medicine and Philippine General Hospital, University of the Philippines Manila, Manila, Philippines. Electronic address: .; Sedano LSP

Subjects: Angioedema/Angioedema/Angioedema/*chemically induced ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*adverse effects ; Fibrinolytic Agents/Fibrinolytic Agents/Fibrinolytic Agents/*adverse effects

  • Source: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Publisher: Saunders Country of Publication: United States NLM ID: 9111633 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage.

  • Authors : Ling QS; School of Pharmacy, Yantai University, Yantai, 264005, China.; Department of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai, 200433, China.

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Aortic Diseases/Aortic Diseases/Aortic Diseases/*prevention & control

  • Source: Acta pharmacologica Sinica [Acta Pharmacol Sin] 2021 Jun; Vol. 42 (6), pp. 871-884. Date of Electronic Publication: 2021 May 17.Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?

  • Authors : Culman J; Institute of Experimental and Clinical Pharmacology, University Hospital of Schleswig-Holstein, Campus Kiel, Hospitalstraße 4, 24105, Kiel, Germany.; Jacob T

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Brain Ischemia/Brain Ischemia/Brain Ischemia/*drug therapy ; Neuroprotective Agents/Neuroprotective Agents/Neuroprotective Agents/*pharmacology

  • Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2017 Sep; Vol. 390 (9), pp. 949-959. Date of Electronic Publication: 2017 Jul 02.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Brain-Derived Neurotrophic Factor Knockdown Blocks the Angiogenic and Protective Effects of Angiotensin Modulation After Experimental Stroke.

  • Authors : Fouda AY; Charlie Norwood VA Medical Center and Center for Pharmacy and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, USA.; Alhusban A

Subjects: Angiogenesis Inducing Agents/Angiogenesis Inducing Agents/Angiogenesis Inducing Agents/*therapeutic use ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Brain-Derived Neurotrophic Factor/Brain-Derived Neurotrophic Factor/Brain-Derived Neurotrophic Factor/*antagonists & inhibitors

  • Source: Molecular neurobiology [Mol Neurobiol] 2017 Jan; Vol. 54 (1), pp. 661-670. Date of Electronic Publication: 2016 Jan 12.Publisher: Humana Press Country of Publication: United States NLM ID: 8900963 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive Rats.

  • Authors : Drews HJ; Department of Clinical Pharmacology, University Hospital of Tuebingen, Auf der Morgenstelle 8, 72076, Tuebingen, Germany.; Yenkoyan K

Subjects: Amyloid beta-Peptides/Amyloid beta-Peptides/Amyloid beta-Peptides/*metabolism ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Glymphatic System/Glymphatic System/Glymphatic System/*chemistry

  • Source: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2019 Jul; Vol. 16 (3), pp. 725-740.Publisher: Springer Country of Publication: United States NLM ID: 101290381 Publication Model: Print Cited Medium: Internet ISSN: 1878-7479

Record details

Read More Add to Saved list
×
Academic Journal

Therapy with the Combination of Amlodipine and Irbesartan Has Persistent Preventative Effects on Stroke Onset Associated with BDNF Preservation on Cerebral Vessels in Hypertensive Rats.

  • Authors : Hasegawa Y; Department of Pharmacology and Molecular Therapeutics, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto-shi, Kumamoto-ken, 8608556, Japan.; Nakagawa T

Subjects: Amlodipine/Amlodipine/Amlodipine/*pharmacology ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Biphenyl Compounds/Biphenyl Compounds/Biphenyl Compounds/*pharmacology

  • Source: Translational stroke research [Transl Stroke Res] 2016 Feb; Vol. 7 (1), pp. 79-87. Date of Publisher: Springer Country of Publication: United States NLM ID: 101517297 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Improvement of Plasma Biomarkers after Switching Stroke Patients from Other Angiotensin II Type I Receptor Blockers to Olmesartan.

  • Authors : Tada Y; Department of Neurosurgery, Institute of Health Biosciences, Tokushima University, Tokushima, Japan. Electronic address: .; Yagi K

Subjects: Drug Substitution*; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use

  • Source: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Publisher: Saunders Country of Publication: United States NLM ID: 9111633 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockers].

  • Authors : Mogi M; Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University, Graduate School of Medicine.; Horiuchi M

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/*therapeutic use ; Stroke/Stroke/Stroke/*prevention & control

  • Source: Nihon rinsho. Japanese journal of clinical medicine [Nihon Rinsho] 2006 Oct 28; Vol. 64 Suppl 7, pp. 724-9.Publisher: Nippon Rinsho Co Country of Publication: Japan NLM ID: 0420546 Publication Model: Print Cited Medium: Print ISSN: 0047-1852 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

Post-stroke losartan and captopril treatments arrest hemorrhagic expansion in SHRsp without lowering blood pressure.

  • Authors : Smeda JS; Division of BioMedical Sciences, Memorial University of Newfoundland, St. John's, Newfoundland, Canada. Electronic address: .; Watson D

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/*pharmacology ; Blood Pressure/Blood Pressure/Blood Pressure/*drug effects

  • Source: Vascular pharmacology [Vascul Pharmacol] 2018 Dec; Vol. 111, pp. 26-35. Date of Electronic Publication: 2018 Aug 13.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130615 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  258 results for ""Angiotensin II Type 1 Receptor Blockers""